Company Description

BioJiva is a clinical stage pharmaceutical company pioneering the development of first-in-class therapeutics to treat degenerative diseases resulting from Lipid peroxidation (LPO). BioJiva has developed a series of oxidation resistant armored Polyunsaturated Fatty Acids (PUFAs) as drug interventions to mitigate LPO.